[go: up one dir, main page]

AU2007235353A1 - Use of combination preparations containing thrombin receptor antagonists for treating cardiovascular disorders - Google Patents

Use of combination preparations containing thrombin receptor antagonists for treating cardiovascular disorders Download PDF

Info

Publication number
AU2007235353A1
AU2007235353A1 AU2007235353A AU2007235353A AU2007235353A1 AU 2007235353 A1 AU2007235353 A1 AU 2007235353A1 AU 2007235353 A AU2007235353 A AU 2007235353A AU 2007235353 A AU2007235353 A AU 2007235353A AU 2007235353 A1 AU2007235353 A1 AU 2007235353A1
Authority
AU
Australia
Prior art keywords
inhibitors
pharmaceutical composition
cardiovascular
group
agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2007235353A
Other languages
English (en)
Inventor
William J. Greenlee
Enrico P. Veltri
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme LLC
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38458156&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU2007235353(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Corp filed Critical Schering Corp
Publication of AU2007235353A1 publication Critical patent/AU2007235353A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2007235353A 2006-04-06 2007-04-05 Use of combination preparations containing thrombin receptor antagonists for treating cardiovascular disorders Abandoned AU2007235353A1 (en)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
US79046906P 2006-04-06 2006-04-06
US60/790,469 2006-04-06
US80861106P 2006-05-26 2006-05-26
US60/808,611 2006-05-26
US80978506P 2006-05-31 2006-05-31
US60/809,785 2006-05-31
US83948406P 2006-08-23 2006-08-23
US83947406P 2006-08-23 2006-08-23
US60/839,474 2006-08-23
US60/839,484 2006-08-23
PCT/US2007/008612 WO2007117621A1 (en) 2006-04-06 2007-04-05 Use of combination preparations containing thrombin receptor antagonists for treating cardiovascular disorders

Publications (1)

Publication Number Publication Date
AU2007235353A1 true AU2007235353A1 (en) 2007-10-18

Family

ID=38458156

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2007235353A Abandoned AU2007235353A1 (en) 2006-04-06 2007-04-05 Use of combination preparations containing thrombin receptor antagonists for treating cardiovascular disorders

Country Status (11)

Country Link
EP (1) EP2001471A1 (es)
JP (1) JP2009532487A (es)
AR (1) AR060354A1 (es)
AU (1) AU2007235353A1 (es)
BR (1) BRPI0710840A2 (es)
CA (1) CA2648613A1 (es)
MX (1) MX2008012933A (es)
NO (1) NO20084677L (es)
PE (1) PE20080183A1 (es)
TW (1) TW200812619A (es)
WO (1) WO2007117621A1 (es)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105125504A (zh) * 2015-09-17 2015-12-09 青岛华之草医药科技有限公司 一种降血脂药物匹伐他汀钙组合物颗粒剂

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI367112B (en) * 2006-06-30 2012-07-01 Schering Corp Immediate-release tablet formulations of a thrombin receptor antagonist
CA2708418C (en) * 2007-12-11 2013-11-12 Bayer Schering Pharma Aktiengesellschaft Oxazolidinones for the treatment and/or prophylaxis of heart failure
MX2010007527A (es) * 2008-01-11 2010-10-05 Eisai R&D Man Co Ltd Composicion farmaceutica, uso del derivado 2-iminopirrolidina para la produccion de la composicion farmaceutica y kit para el tratamiento o mejora de enfermedaes cardiacas.
WO2009124103A2 (en) * 2008-04-02 2009-10-08 Schering Corporation Combination therapies comprising par1 antagonists with par4 antagonists
WO2010144339A2 (en) * 2009-06-08 2010-12-16 Schering Corporation A thrombin receptor antagonist and clopidogrel fixed dose tablet
US20130183392A1 (en) * 2011-07-15 2013-07-18 Steven Moore Insect repellant and system
KR20140028971A (ko) * 2012-08-31 2014-03-10 한미약품 주식회사 아토바스타틴, 이르베살탄 및 탄산마그네슘을 포함하는 이층정 복합제제

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040192753A1 (en) * 2000-06-15 2004-09-30 Samuel Chackalamannil Methods of use of thrombin receptor antagonists
US7235567B2 (en) * 2000-06-15 2007-06-26 Schering Corporation Crystalline polymorph of a bisulfate salt of a thrombin receptor antagonist
US7488742B2 (en) * 2000-06-15 2009-02-10 Schering Corporation Thrombin receptor antagonists
ATE455774T1 (de) * 2002-04-16 2010-02-15 Schering Corp Trizyklische thrombinrezeptorantagonisten
CA2567981C (en) * 2004-05-28 2010-08-31 Schering Corporation Constrained himbacine analogs as thrombin receptor antagonists
RU2408594C2 (ru) * 2004-10-08 2011-01-10 Шеринг Корпорейшн Антагонисты рецептора тромбина
US7776889B2 (en) * 2005-03-31 2010-08-17 Schering Corporation Spirocyclic thrombin receptor antagonists
JP2009521472A (ja) * 2005-12-22 2009-06-04 シェーリング コーポレイション 心肺手術の合併症の予防としてのトロンビンレセプターアンタゴニスト
AR058400A1 (es) * 2005-12-22 2008-01-30 Schering Corp Derivados de oxazoloisoquinolina como antagonistas del receptor de trombina

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105125504A (zh) * 2015-09-17 2015-12-09 青岛华之草医药科技有限公司 一种降血脂药物匹伐他汀钙组合物颗粒剂

Also Published As

Publication number Publication date
BRPI0710840A2 (pt) 2011-08-23
EP2001471A1 (en) 2008-12-17
MX2008012933A (es) 2008-10-15
WO2007117621A1 (en) 2007-10-18
TW200812619A (en) 2008-03-16
CA2648613A1 (en) 2007-10-18
NO20084677L (no) 2008-11-05
AR060354A1 (es) 2008-06-11
JP2009532487A (ja) 2009-09-10
PE20080183A1 (es) 2008-03-10

Similar Documents

Publication Publication Date Title
AU2007235353A1 (en) Use of combination preparations containing thrombin receptor antagonists for treating cardiovascular disorders
JP6624616B2 (ja) ｓＧＣ刺激剤
RU2582679C2 (ru) СТИМУЛЯТОРЫ sGC
US20160175307A1 (en) sGC STIMULATORS
KR101918375B1 (ko) 이온 채널 조정제로서의 융합된 헤테로시클릭 화합물
US20230270718A1 (en) Methods of treating diabetic kidney disease
EP3215157B1 (en) Apilimod for use in the treatment of melanoma
JP2010518181A (ja) 心血管疾患の処置のためのラノラジンの使用
EP2332535A1 (en) Solid pharmaceutical composition
KR20210018926A (ko) 신규한 지질
KR20080092436A (ko) 약물 조합
KR20170098812A (ko) 신장암의 치료에 사용하기 위한 아필리모드
JP5084736B2 (ja) 肺高血圧を処置するためのジアリールウレア
US20070238674A1 (en) Tra combination therapies
JP2009517411A (ja) 心血管及び関連病状の処置のための調剤
CN101472589A (zh) 用于治疗心血管疾病的含有凝血酶受体拮抗剂的组合物制剂之用途
EP2241315B1 (en) Pharmaceutical composition, use of 2-iminopyrrolidine derivative for production of pharmaceutical composition, and kit for treatment or amelioration of heart diseases
KR101871613B1 (ko) 이온 채널 조정제로서의 융합된 헤테로시클릭 화합물
MX2011009413A (es) Combinacion de una indazolilaminopirrolotriazina y taxano para tratamiento contra cancer.
US20170240539A1 (en) Preparation and Use of Cyclic Sulfonamide Derivatives as PAR-1 Receptor Antagonists
US20200222414A1 (en) Combination of a pi3k-inhibitor with an androgen receptor antagonist
JP2017019724A (ja) 置換ピリジン化合物および他の医薬の組み合わせ

Legal Events

Date Code Title Description
MK1 Application lapsed section 142(2)(a) - no request for examination in relevant period